Hiremagalur N. Jayaram

Statistics

Publications

Citations

3.5K

H-Index

Active since

1974

Affiliations

Indiana University – Purdue University Indianapolis(Current)

Indiana University School of Medicine

Richard L. Roudebush VA Medical Center

National Cancer Institute

National Institutes of Health

Hiremagalur N. Jayaram is an author at Indiana University – Purdue University Indianapolis specializing in pharmacology, enzyme inhibition, and medicine.

Publications per year

1974–2017

Publications

Initial studies on the mechanism of action of a new oncolytic thiazole nucleoside, 2-β-d-ribofuranosylthiazole-4-carboxamide NSC 286193)

Hiremagalur N. Jayaram, Robert L. Dion, Robert I. Glazer et al. · Biochemical Pharmacology · 1982 · 144 citations

Medicine, Medicinal Chemistry, Oncology +9

Consequences of IMP Dehydrogenase Inhibition, and its Relationship to Cancer and Apoptosis

Hiremagalur N. Jayaram, Michael Grusch, David A. Cooney et al. · Current Medicinal Chemistry · 1999 · 135 citations

Medicine, Oncology, Pharmacology +17

Biochemically directed therapy of leukemia with tiazofurin, a selective blocker of inosine 5'-phosphate dehydrogenase activity.

Guido Tricot, Hiremagalur N. Jayaram, Elizabeth Lapis et al. · PubMed · 1989 · 127 citations

Medicine, Pharmacology, Pharmacotherapy +16

The conversion of 2-β-D-ribofuranosylthiazole-4-carboxamide to an analogue of NAD with potent IMP dehydrogenase-inhibitory properties

David A. Cooney, Hiremagalur N. Jayaram, Gulilat Gebeyehu et al. · Biochemical Pharmacology · 1982 · 122 citations

Life Sciences, Biochemistry, Medicinal Chemistry +11

Furanfurin and Thiophenfurin: Two Novel Tiazofurin Analogs. Synthesis, Structure, Antitumor Activity, and Interactions with Inosine Monophosphate Dehydrogenase

Palmarisa Franchetti, Loredana Cappellacci, Mario Grifantini et al. · Journal of Medicinal Chemistry · 1995 · 120 citations

Medicine, Medicinal Chemistry, Pharmacology +8

1–5 of 92